Literature DB >> 20533377

Synapse loss in dementias.

Ryan Clare1, Victoria G King, Martin Wirenfeldt, Harry V Vinters.   

Abstract

Synaptic transmission is essential for nervous system function, and its dysfunction is a known major contributing factor to Alzheimer's-type dementia. Antigen-specific immunochemical methods are able to characterize synapse loss in dementia through the quantification of various synaptic proteins involved in the synaptic cycle. These immunochemical methods applied to the study of Alzheimer's disease (AD) brain specimens have correlated synaptic loss with particularly toxic forms of amyloid-beta protein and have also established synapse loss as the best correlate of dementia severity. A significant but comparatively circumscribed amount of literature describes synaptic decline in other forms of dementia. Ischemic vascular dementia (IVD) is quite heterogeneous, and synapse loss in IVD seems to be variable among IVD subtypes, probably reflecting its variable neuropathologic correlates. Loss of synaptic protein has been identified in vascular dementia of the Binswanger type and Spatz-Lindenberg's disease. Here we demonstrate a significant loss of synaptophysin density within the temporal lobe of frontotemporal dementia (FTD) patients.

Entities:  

Mesh:

Year:  2010        PMID: 20533377      PMCID: PMC3068914          DOI: 10.1002/jnr.22392

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  56 in total

1.  Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease.

Authors:  M N Sabbagh; J Corey-Bloom; P Tiraboschi; R Thomas; E Masliah; L J Thal
Journal:  Arch Neurol       Date:  1999-12

Review 2.  Vascular cognitive impairment.

Authors:  Ola A Selnes; Harry V Vinters
Journal:  Nat Clin Pract Neurol       Date:  2006-10

3.  Absence of synaptophysin near cortical neurons containing oligomer Abeta in Alzheimer's disease brain.

Authors:  Ken-Ichi Ishibashi; Takami Tomiyama; Kazuchika Nishitsuji; Mitsuhiro Hara; Hiroshi Mori
Journal:  J Neurosci Res       Date:  2006-08-15       Impact factor: 4.164

Review 4.  Frontotemporal lobar degeneration: current concepts in the light of recent advances.

Authors:  Samir Kumar-Singh; Christine Van Broeckhoven
Journal:  Brain Pathol       Date:  2007-01       Impact factor: 6.508

5.  Neuritic pathology as a correlate of synaptic loss in dementia with lewy bodies.

Authors:  Gonzalo J Revuelta; Andrea Rosso; Carol F Lippa
Journal:  Am J Alzheimers Dis Other Demen       Date:  2008 Feb-Mar       Impact factor: 2.035

6.  Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction.

Authors:  P Hemachandra Reddy; Geethalakshmi Mani; Byung S Park; Joline Jacques; Geoffrey Murdoch; William Whetsell; Jeffrey Kaye; Maria Manczak
Journal:  J Alzheimers Dis       Date:  2005-04       Impact factor: 4.472

Review 7.  Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease.

Authors:  I Ferrer
Journal:  Cerebellum       Date:  2002-07       Impact factor: 3.847

8.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations.

Authors:  Ian R A Mackenzie; Manuela Neumann; Eileen H Bigio; Nigel J Cairns; Irina Alafuzoff; Jillian Kril; Gabor G Kovacs; Bernardino Ghetti; Glenda Halliday; Ida E Holm; Paul G Ince; Wouter Kamphorst; Tamas Revesz; Annemieke J M Rozemuller; Samir Kumar-Singh; Haruhiko Akiyama; Atik Baborie; Salvatore Spina; Dennis W Dickson; John Q Trojanowski; David M A Mann
Journal:  Acta Neuropathol       Date:  2008-11-18       Impact factor: 17.088

9.  Cerebral microinfarcts associated with severe cerebral beta-amyloid angiopathy.

Authors:  Virawudh Soontornniyomkij; Matthew D Lynch; Sherin Mermash; Justine Pomakian; Haleh Badkoobehi; Ryan Clare; Harry V Vinters
Journal:  Brain Pathol       Date:  2009-07-16       Impact factor: 6.508

10.  National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards.

Authors:  Vladimir Hachinski; Costantino Iadecola; Ron C Petersen; Monique M Breteler; David L Nyenhuis; Sandra E Black; William J Powers; Charles DeCarli; Jose G Merino; Raj N Kalaria; Harry V Vinters; David M Holtzman; Gary A Rosenberg; Anders Wallin; Martin Dichgans; John R Marler; Gabrielle G Leblanc
Journal:  Stroke       Date:  2006-08-17       Impact factor: 7.914

View more
  57 in total

1.  Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease.

Authors:  Edward J Goetzl; Dimitrios Kapogiannis; Janice B Schwartz; Iryna V Lobach; Laura Goetzl; Erin L Abner; Gregory A Jicha; Anna M Karydas; Adam Boxer; Bruce L Miller
Journal:  FASEB J       Date:  2016-09-06       Impact factor: 5.191

2.  Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.

Authors:  Gorka Gerenu; Kai Liu; Jeremy E Chojnacki; John M Saathoff; Pablo Martínez-Martín; George Perry; Xiongwei Zhu; Hyoung-Gon Lee; Shijun Zhang
Journal:  ACS Chem Neurosci       Date:  2015-05-04       Impact factor: 4.418

3.  Valosin-containing protein and neurofibromin interact to regulate dendritic spine density.

Authors:  Hsiao-Fang Wang; Yu-Tzu Shih; Chiung-Ya Chen; Hsu-Wen Chao; Ming-Jen Lee; Yi-Ping Hsueh
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

4.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

5.  White matter damage and glymphatic dysfunction in a model of vascular dementia in rats with no prior vascular pathologies.

Authors:  Poornima Venkat; Michael Chopp; Alex Zacharek; Chengcheng Cui; Li Zhang; Qingjiang Li; Mei Lu; Talan Zhang; Amy Liu; Jieli Chen
Journal:  Neurobiol Aging       Date:  2016-11-19       Impact factor: 4.673

6.  Diet-induced obesity attenuates cytokine production following an immune challenge.

Authors:  Katherine M Baumgarner; Sharay Setti; Carolyn Diaz; Alyssa Littlefield; Amanda Jones; Rachel A Kohman
Journal:  Behav Brain Res       Date:  2014-03-20       Impact factor: 3.332

7.  β amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice.

Authors:  Clark A Briggs; Corinne Schneider; Jill C Richardson; Grace E Stutzmann
Journal:  Neurobiol Aging       Date:  2013-01-18       Impact factor: 4.673

8.  REGION-SPECIFIC NEURON AND SYNAPSE LOSS IN THE HIPPOCAMPUS OF APPSL/PS1 KNOCK-IN MICE.

Authors:  Ivona Brasnjevic; Roy Lardenoije; Christoph Schmitz; Nicolien Van Der Kolk; Dara L Dickstein; Hisaaki Takahashi; Patrick R Hof; Harry W M Steinbusch; Bart P F Rutten
Journal:  Transl Neurosci       Date:  2013-03-01       Impact factor: 1.757

9.  Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease.

Authors:  Edward J Goetzl; Erin L Abner; Gregory A Jicha; Dimitrios Kapogiannis; Janice B Schwartz
Journal:  FASEB J       Date:  2018-01-04       Impact factor: 5.191

10.  The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes.

Authors:  Benjamin M Schwenk; Christina M Lang; Sebastian Hogl; Sabina Tahirovic; Denise Orozco; Kristin Rentzsch; Stefan F Lichtenthaler; Casper C Hoogenraad; Anja Capell; Christian Haass; Dieter Edbauer
Journal:  EMBO J       Date:  2013-12-19       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.